Clinical Trial Update: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic study of the itraconazole oral solution JK1211 (Itrizole) in patients with invasive fungal infections; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Blastomycosis
• Candidiasis
• Cryptococcosis
• Histoplasmosis
• Invasive Fungal Infection

Drugs mentioned

• Itrizole (Itraconazole)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Mycoses, Candidiasis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-25